Rabbit antithymocyte globulin versus basiliximab in renal transplantation. - Wikidata - wikimedia - TriplyDB

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

http://www.wikidata.org/entity/Q34580374

about

Interleukin 2 receptor antagonists for kidney transplant recipients The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage Acute kidney injury: preclinical innovations, challenges, and opportunities for translation New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Delayed graft function in the kidney transplant Monoclonal antibody therapy and renal transplantation: focus on adverse effects Biologics in organ transplantation Current state of renal transplant immunosuppression: Present and future Selection of induction therapy in kidney transplantation A Rationale for Age-Adapted Immunosuppression in Organ Transplantation The feasibility of lung transplantation in HIV-seropositive patients Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.Thymoglobulin--new approaches to optimal outcomes.Use of monoclonal antibodies in renal transplantation.Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.Mechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG).Cytopenia Occurrence in Kidney Transplant Recipients Within Early Post-transplant Period.Polyclonal antithymocyte globulin and cardiovascular disease in kidney transplant recipients Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons.Transplantation immunology: solid organ and bone marrow.Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation.Management of cytomegalovirus infection and disease in liver transplant recipients.Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.Early rehospitalization after kidney transplantation: assessing preventability and prognosis.Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study.Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.Have we overestimated the benefit of human(ized) antibodies?The feasibility and applications of non-invasive cardiac output monitoring, thromboelastography and transit-time flow measurement in living-related renal transplantation surgery: results of a prospective pilot observational study.Current concepts on cytomegalovirus infection after liver transplantation Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations.Survival of living-related kidney graft recipients in the era of modern immunosuppressive treatment.Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression.Association of antibody induction immunosuppression with cancer after kidney transplantation.

P2860

Q24240492-90586558-93C8-4940-91CA-B7057414994A Q26774993-C659AE1E-8D7F-4524-9004-7B1A541F1A33 Q26784305-6954A69A-4E1C-47FC-9F71-1EF8F3411307 Q26786667-08B11F0D-7BB8-455F-AE50-4BA454CDA495 Q26823090-7D61378E-BEF3-4590-9D41-356E3FBFA4BA Q26824506-8E910895-EA1E-423A-8B99-4996EF6D263A Q26826880-386F0AB3-B0AB-4774-B5C1-9BACFA97C64F Q26829578-92F51F67-66B3-4FAC-8DD7-7C3B51274C19 Q26829789-FFDD1734-D322-4F67-9ACF-9569D9954797 Q26864234-0F419D2E-F5AA-4238-BE73-88C4991AC84F Q28080954-DD4465A7-FC20-4A79-82E4-D9DAF249DE0D Q28242762-0CFD916C-5375-466D-85FC-A2F5C4061E39 Q28740458-939300BC-01CF-4B79-B85B-DAEAF2A0B19C Q30389408-1BF2ABE2-2B22-47C9-B377-C927C688B23E Q30987986-B9BBE9A7-2E2F-4392-869E-4D76CA821472 Q33388015-FEDC2219-C943-4EFA-A044-568177BD741B Q33396236-FCA77454-54E0-463A-8B0F-5E7F9F3ED69E Q33415937-CEF561E0-5BD0-411C-9F75-9F45680F89F4 Q33422771-9707DDCA-B20F-4282-A81E-E15DEC1A816B Q33440336-1F00B728-BFF5-4767-AB86-BA7AF02AAFFA Q33660602-419DE9CA-B3DD-459D-9BC2-8AF93834E6B2 Q33708427-462DAE64-CECA-429B-A89F-AFD9861405B0 Q33803804-D5090809-3891-436A-B725-3B5AF47E5392 Q33834302-05FAFDB5-88E4-4C71-AF1D-0A40EFB8E628 Q33845124-2F25F00D-B895-476E-8812-08B11CD950B4 Q33848529-DC9C73AC-898D-4FA7-9390-E534020A2108 Q33938964-8541943E-2B43-4AFD-8909-65B21A3265BC Q33942207-2C4A7DFD-9DC4-4CD6-AD27-55DA53401218 Q34027642-D8884E12-7946-49E1-8BB9-AD3F9C5B0D9B Q34077023-41E4CC41-D9C8-424F-BC92-FE8F01BC7C6F Q34082857-EE158F14-14E2-4250-AE04-CE563B31F733 Q34142714-51EC53D1-1751-4985-859A-AEA9E759A185 Q34152325-A41200B0-6C80-45A6-B4CF-320FC390A679 Q34390310-4596C905-52F0-4C0E-81D9-A58B07A6EF56 Q34616147-43F6050C-DAAC-4FF5-BC61-80F9F35B37BF Q34796915-BA84114A-D927-4182-9462-51CF9F734E8A Q35028105-8E041A1D-2759-4970-A9FB-619AE65A5086 Q35059593-91077B72-5CED-43CB-89FE-9A774338EF2D Q35175413-4A23DEA6-EA79-4769-9448-1107450D5E9C Q35513074-C83B393B-6A3B-4E2F-8F1B-B7B8C8B117C6

P2860

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

http://www.wikidata.org/entity/Q34580374

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@ast

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@en

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@nl

type

label

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@ast

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@en

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@nl

prefLabel

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@ast

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@en

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@nl

P1433

Q34580374-EA841911-8EB9-439C-8D7D-9A3286BD7AEE

P1476

Q34580374-139A1E74-242B-4DA8-9A2F-207E4C226CB8

P2093

Q34580374-0028C642-C807-465D-A923-9066F0AE0276

Q34580374-49C00782-4559-4372-8ED3-666E56830684

Q34580374-4F1122CC-8E7B-4C52-BCF7-0973E3409DD6

Q34580374-67EB0AEE-FB70-4D2A-AE09-A105814A487A

Q34580374-6C2504E8-77EE-47D0-86DE-2123A124BBC0

Q34580374-6D0CCE6D-E5CA-4C50-A9B3-5DA9C8D12830

P304

Q34580374-8B0FAC9D-F0EF-41CD-B0FD-C4C14705A933

P31

Q34580374-68DFBD7F-B05E-4C44-94D3-0456A2D38C83

P356

Q34580374-BE716CE8-BD44-4473-9BD5-88E1375950BE

P407

Q34580374-0D1576E5-0140-4386-B558-DAC7702CAC7A

P433

Q34580374-F7D778A6-2C8F-495D-8EA0-540B3AA62BA8

P478

Q34580374-3DB53055-F567-4677-B81F-35536002DB00

P577

Q34580374-BD2B8823-A136-437A-8529-B93C00B938E3

P698

Q34580374-500FB3BC-32C6-4CB4-B4A2-B78621C942B7

P356

P1433

The New England Journal of Medicine

P1476

Rabbit antithymocyte globulin versus basiliximab in renal transplantation.

@en

P2093

Daniel C Brennan

http://www.w3.org/2001/XMLSchema#string

Diane Cibrik

http://www.w3.org/2001/XMLSchema#string

Domingo Del Castillo

http://www.w3.org/2001/XMLSchema#string

John A Daller

http://www.w3.org/2001/XMLSchema#string

Kathleen D Lake

http://www.w3.org/2001/XMLSchema#string

Thymoglobulin Induction Study Group

http://www.w3.org/2001/XMLSchema#string

P304

1967-1977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA060068

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

355

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17093248

http://www.w3.org/2001/XMLSchema#string